Skip to main content

Predictive Markers in Daily Anatomic Pathology

Edited by:

Fernando Augusto Soares, MD, PhD, D'Or Pathology and University of São Paulo, Brazil
Isabela Werneck da Cunha, MD, PhD, Rede D'Or Institute for Research and Education, Brazil and Department of Pathology, Rede D’Or/Sao Luiz Hospital, Sao Paulo, Brazil
Mariana Petaccia de Macedo, MD, PhD,  Anatomic Pathology, Rede D'Or Hospitals, São Paulo, Brazil
Gabriel S. Macedo, B.Sc, MSc, PhD, Rede D'Or, São Paulo, Brazil

Submission Status: Closed

This collection is no longer accepting submissions.

Surgical and Experimental Pathology is calling for submissions to our Collection on 'Predictive Markers in Daily Anatomic Pathology.' This Collection aims to shed light on the latest advancements in understanding and utilizing Predictive Markers to enhance diagnostic accuracy, treatment selection, and patient outcomes.

About the collection

Surgical and Experimental Pathology is calling for submissions to our Collection on 'Predictive Markers in Daily Anatomic Pathology.' 

In the field of anatomic pathology, predictive markers serve as invaluable tools for predicting disease behavior, prognosis, and response to treatment. They are biomolecules, genetic alterations, or morphological features that provide insights into a patient's disease trajectory and aid in tailoring personalized treatment strategies.

Predictive markers play a crucial role in guiding diagnostic and therapeutic decisions, ultimately leading to improved patient care. This Collection aims to shed light on the latest advancements in understanding and utilizing these markers to enhance diagnostic accuracy, treatment selection, and patient outcomes.

Through the collaborative efforts of pathologists, researchers, and clinicians, this Collection seeks to bridge the gap between scientific discovery and real-world application. By exploring the predictive markers in daily anatomic pathology, we strive to improve the quality of care provided to patients.


Image credit: Â© Gabriel / Generated with AI / Stock.adobe.com

  1. Sarcomas are tumors of mesenchymal origin that remain with poor prognosis. This review highlights some emerging predictive biomarkers that could drive personalized therapy, focusing on KIT, TP53, MDM2, CDK4 mu...

    Authors: Luiza Fadul Gallas, André Morales Pacca and Rodrigo de Andrade Natal
    Citation: Surgical and Experimental Pathology 2024 7:24
  2. Endometrial carcinoma (EC) is the most common gynecologic malignancy in high-income countries, with its incidence and mortality rising globally, particularly in countries undergoing rapid socioeconomic transit...

    Authors: Janaína Nagel, Rafael Bispo Paschoalini, Patrícia Sodré Dias Barreto, Caroline Haydn Credidio, Eduardo Paulino and Maria Del Pilar Estevez-Diz
    Citation: Surgical and Experimental Pathology 2024 7:21
  3. Predictive biomarkers of response to therapy are fundamental for the personalized therapeutic management of patients with colorectal carcinoma (CRC). The main predictive biomarkers related to CRC are the misma...

    Authors: Antonio Hugo José Fróes Marques Campos, Luciana Campi Auresco, Lidiane Vieira Marins, Paulo Henrique do Amor Divino, Jorge Sabbaga and Paulo Marcelo Hoff
    Citation: Surgical and Experimental Pathology 2024 7:20
  4. Gastric cancer is the fifth most common cause of cancer-related deaths globally, with a decreasing but still high number of cases. Although there have been improvements in treatment choices, the expected survi...

    Authors: Marina Nishimuni, Laura Carolina Lopez Claro and Maria Ignez Freitas Melro Braghiroli
    Citation: Surgical and Experimental Pathology 2024 7:19
  5. Cholangiocarcinoma, a malignant neoplasm of the biliary system, poses a significant challenge in clinical practice due to its increasing incidence and diagnostic and therapeutic complexity. This review address...

    Authors: Lidiane Vieira Marins, Camila Motta Venchiarutti Moniz, Cecília Souza Freire and Antonio Hugo José Fróes Marques Campos
    Citation: Surgical and Experimental Pathology 2024 7:16
  6. Urologic pathology is rapidly evolving to adopt growing knowledge of molecular pathways involved in genitourinary neoplasm. Many prognostic and predictive biomarkers are under active research and some of them ...

    Authors: Mariana Andozia Morini, Daniel Abensur Athanazio, Luiza Fadul Gallas, José Maurício Mota, Stephania Martins Bezerra, João Lobo, María Belén Molina Froján and Andres Acosta
    Citation: Surgical and Experimental Pathology 2024 7:15
  7. Thyroid cancer is one of the most common types of cancer worldwide. It is a spectrum of different diseases, ranging from very indolent to lethal tumors. Differentiated Thyroid Carcinoma (DTC), the most common ...

    Authors: Humberto Carvalho Carneiro, Rodrigo de Andrade Natal, Evelin Cavalcante Farias, Aline Almeida Bastos, Leila Guastapaglia, Alanna Mara Pinheiro Sobreira Bezerra and Ana Amélia Fialho de Oliveira Hoff
    Citation: Surgical and Experimental Pathology 2024 7:14
  8. Since the FDA approved immune-enhancing therapies for patients with high microsatellite instability (MSI-H) and/or mismatch repair deficiency (dMMR), recognizing these biomarkers in solid tumors has gained cli...

    Authors: Milena Massumi Kozonoe, Jacqueline Justino Nabhen, Bruno Ribeiro Batista, Lucas Novello, Edenir Inêz Palmero, Sérgio Ossamu Ioshii and Júlia Costa Linhares
    Citation: Surgical and Experimental Pathology 2024 7:13

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. 

Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Editorial Manager. During the submission process you will be asked whether you are submitting to a Collection, please select "Predictive Markers in Daily Anatomic Pathology" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.